Cannabis Law Report

NOVEMBER 20, 2019

Since a new law took effect a year ago, England’s National Health Service (NHS) has reimbursed patients on only 18 occasions for “unlicensed” cannabis-based products that have not undergone clinical trials, according to government data. All other cannabis-based medicines are unlicensed. Read the full story.

Clinical Trials 45

Clinical Trials Data Medicine Patients 45

Cannabis Law Report

JUNE 19, 2022

Partnership will focus on the collection and analysis of digital biomarkers to identify signs of response and relapse in upcoming Phase 2 clinical trials. However, we need rigorous clinical trials to ensure that this promise is realised. June 14, 2022 02:00 AM Eastern Daylight Time. Ksana Health – www.ksanahealth.com.

Clinical Trials 52

Clinical Trials Patients Research and Development Treatment 52

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. 14th at 11:00 a.m. PT (2:00 p.m.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

The Cannigma

FEBRUARY 2, 2021

This article was originally published on Analytical Cannabis and appears here with permission. . In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. Of these consumers, over half said the drug had a beneficial clinical effect on their condition.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Cannabis Law Report

FEBRUARY 2, 2022

UK website Leafie writes… The findings of a study published in JAMA Psychiatry have revealed that road testing for cannabis impairment may be putting up to 1.4m medical cannabis users at risk of unfair prosecution, according to a report by Volteface. Further simulator tests were given at 30 minutes, 1.5, hours after smoking.

Medicine 52

Medicine Clinical Trials Consumption Sleep 52

The Cannigma

JULY 1, 2022

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis problem.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.

CBD 105

CBD Data Sleep Clinical Trials 105

Project CBD

AUGUST 6, 2019

Over 200 scientists from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpiblished data. None of the participants had been using any cannabinoid-based products prior to this study.

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

Veriheal

MARCH 23, 2023

One of the proposed bills would amend the Cannabis Control Law during the current 150-day Diet session, which launched on Monday, January 23. Based on Japan’s Cannabis Control Law—A.K.A. Japan’s latest Cannabis Control Law revisions would apply to pharmaceutical-grade medicinal cannabis products. ‘1948 Law No.

Legalization 81

Legalization Marijuana Clinical Trials Seed-To-Sale 81

Healer

MARCH 26, 2021

Some researchers believe cannabis can help wean prescription opioid users off the addictive and potentially deadly drugs. Gresh has joined a growing number of patients who swear by medical cannabis not only as a treatment option for chronic pain, but also as a substitute for prescription opioids used in pain management. March 19, 2021.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Project CBD

AUGUST 6, 2019

Just over 500 participants from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpublished data. None of the participants had been using any cannabinoid-based products prior to this study.

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

The Cannigma

AUGUST 31, 2021

Barely a quarter of cannabis users trust their doctor to provide them with reliable information about medical cannabis and how to use it to treat their medical or health conditions, according to a recent survey. People want to trust their doctors, but doctors need knowledge. We have a ways to go,” Tan said.

Education 101

Education Clinical Trials Medicine Policy 101

Veriheal

JULY 12, 2021

Fortunately, congressional committees are fighting for medical cannabis access for veterans , and states are beginning to take measures to address their veterans , but what is the latest in research and what can one expect? Veterans can expect to find conflicting information regarding the efficacy of cannabis for their PTSD.

Treatment 104

Treatment Sleep Clinical Trials Data 104

Cannabis Law Report

MAY 29, 2022

In May 2019, Denver became the first city to decriminalize psilocybin, followed by Oakland, CA, Washington, D.C., In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] Clinical Trials and Human Subject Protections. and Seattle, among other municipalities.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JULY 4, 2019

The manuscript is part of EMMAC’s collaboration with Imperial College London, forged to deliver a long-term comprehensive research programme designed to inform and shape the future of the medical cannabis therapeutic industry. About EMMAC.

Cannabinoids 40

Cannabinoids Clinical Trials Chronic Pain Medicine 40

Cannabis Law Report

DECEMBER 21, 2021

Also in November, it reported positive data on its standout IND, CYB003. Within a few months, it had completed the first phase of its clinical trial of DMT in combination with supportive psychotherapy and commenced a phase 2a trial. Small Pharma (CVE: DMT ) (OTCMKTS: DMTTF ).

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

The Joint Blog

FEBRUARY 24, 2021

For decades cannabis researchers have been investigating the impact cannabis has on neurological diseases. Numerous trials have been run using medical marijuana and CBD tinctures to treat or reduce the symptoms of Parkinson’s Disease. This is not the first medicinal trial of its kind. This trial was to take 3.5

Treatment 55

Treatment Clinical Trials Collective Patients 55

The Joint Blog

JANUARY 23, 2020

The study is titled “Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review.” ” “Medicinal cannabis has received increased research attention over recent years due to loosening global regulatory changes”, states the study’s abstract.

Clinical Trials 52

Clinical Trials Sleep Marijuana Cannabinoids 52

Cannabis Law Report

NOVEMBER 16, 2021

Believed to be the only IND application ever cleared by the FDA for a Phase 2 trial of a patented drug for delaying aging. Phase 2 trial recruiting begins immediately; efficacy data expected by the end of the first quarter of 2022. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

The Blunt Truth

AUGUST 13, 2019

In March of 2019, the FDA established a Working Group to determine the possible legislative pathways to regulate CBD. On May 31, 2019, the FDA’s Working Group held a public hearing for stakeholders to share their experiences and challenges with CBD products, including information and views related to product safety.

CBD 80

CBD Food Seed-To-Sale Wellness and Beauty 80

Cannabis Law Report

DECEMBER 11, 2021

Since Thailand launched its first cannabis clinic in August 2019, the Public Health Ministry has opened over 500 more nationwide. “More than 40,000 patients have used cannabis to treat their respective illnesses. . “More than 40,000 patients have used cannabis to treat their respective illnesses.

Oil 52

Oil Blood Pressure Concentrates Patients 52

Cannabis Law Report

JULY 6, 2021

In 2019, Dr. Johnson received the R. We look forward to Dr. Johnson’s expertise as we expand our mental health analytical platform and enter clinical trials.” Brinkley Smithers award from the American Association of Addiction Medicine. ” About Ehave, Inc. Ehave, Inc. Forward-Looking Statement Disclaimer.

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97

Cannabis Law Report

NOVEMBER 15, 2021

Although a limited number of CGTs are currently on the market, FDA officials predicted in 2019 that the agency will receive more than 200 investigational new drug applications per year for cell and gene therapies and that by 2025, it expects to have accelerated to 10 to 20 cell and gene therapy approvals per year 1. January 15, 2019.

Research and Development 52

Research and Development Therapy Clinical Trials Supply Chain 52

Cannabis Law Report

JULY 23, 2019

This is particularly the case for cannabis and cannabidiol (CBD) products. As an example, the USPTO allows patents for cannabis inventions but prohibits registering trademarks for cannabis and cannabis products. Koi CBD, LLC is a cannabis company based in California. Laws on Legalised Cannabis.

Law 40

Law Clinical Trials CBD Edibles 40

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. Doctors can prescribe Epidyolex – an oral solution of cannabidiol, which comes from the cannabis plant – if they think it will help sufferers. What is Epidyolex?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Law Report

DECEMBER 21, 2021

All three industries are target markets from Dalrada’s original expansion plan that started in 2019. Healthcare – Biotechnology, data management, and personalized health are primary growth factors of the healthcare industry, Fundera’s research reveals. Workforce – Analyst data reveals that the employment rate at 4.6% (Oct.

Research and Development 52

Research and Development Supply Chain Data Business 52

The Cannigma

JUNE 15, 2021

Like all plants, cannabis contains a plethora of molecules, some of which have specific functions — such as determining the smell, taste and color of the plant, but also what types of effects it can have on you. This is why eating raw cannabis won’t necessarily get you high — it is full of non-decarboxylated THCA. CBD vs THC.

CBD 122

CBD Research and Development Epilepsy Extraction 122

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

JUNE 10, 2021

In short the study learns that legalized states tend not to have their roads overcrowded with stoned drivers and cannabis users like alcohol users self police their behaviour. However, relatively few studies have used self-reported data for this purpose [ 11 , 12 , 13 ]. Under this restriction, we analyzed data from 11,816 respondents.

Policy 59

Policy Safety Marijuana Data 59

Cannabis Law Report

JULY 24, 2019

Marketwatch report… Shares of cannabis company Curaleaf Holdings Inc. July 22, 2019. On your Facebook Social Media Account: • April 8, 2019 posting – “CBD Can be a powerful ally if you’re suffering from chronic inflammation and pain.”. tumbled more than 7% Tuesday and dragged the broader sector lower, after the U.S.

CBD 51

CBD Tincture Pets Chronic Pain 51

Cannabis Law Report

SEPTEMBER 20, 2021

Delic expects to open 15 additional clinics across the country over the coming 18 months, further expanding access to millions who can benefit from psychedelic treatment for a variety of mental health conditions. Transaction Highlights.

Treatment 52

Treatment Media Research and Development Patients 52

Canna Law Blog

NOVEMBER 6, 2021

To acknowledge its impressive safety record and potential for treating depression more effectively than existing therapies, the Food and Drug Administration designated psilocybin a breakthrough therapy in 2018 and 2019 for treating drug-resistant depression and major depressive disorder. For two decades, U.S.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. THC is the primary psychoactive compound in cannabis.) 2 The seeds of C.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JANUARY 20, 2022

ELE-Psilo program expected to enter clinical trials in Q2 2022 and to target the pressing need for rapid-acting antidepressants compatible with existing healthcare infrastructure and insurance. million SPAC sponsored by Silver Spike, an asset manager with deep expertise in health, wellness and cannabis investments. II is a $287.5

Therapy 52

Therapy Research and Development Business Access 52

Cannabis Law Report

JANUARY 9, 2019

A skeptic all his life, it was not until Martin Tindall walked around a Colorado dispensary and saw firsthand how cannabis could lengthen and save lives did he become a believer. I would never have thought to get into the medical cannabis industry, it always just seemed like an excuse for people to get high,” he told Cannabis Law Report.

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

CannaTech

SEPTEMBER 23, 2019

This commentary on the NICE UK cannabis guidelines is originally published by The Academy of Medical Cannabis , the globally leading institute for clinical training and research in cannabis-based medicinal products. Since the early 1990s, Israel has stood at the front line of cannabis medicalization.

Patients 79

Patients Policy Clinical Trials Research and Development 79

The Cannigma

JANUARY 13, 2023

Scientists still don’t understand exactly why migraines happen, nor how to cure the condition – but perhaps cannabis can help. Cannabis users have been reporting anecdotal relief for years, but it’s only recently that research has begun to dig into the complexities of migraines and how – or why – cannabis may be able to bring relief.

Terpenes 132

Terpenes Strains THC Treatment 132